本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2020/9/151 分钟阅读
Post-Marketing Pediatric-Focused Product Safety Reviews; Establishment of a Public Docket; Request for Comments; Correction
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of September 2, 2020. The document announced the availability of post-marketing pediatric-focused safety reviews of products posted between September 23, 2019, and September 1, 2020, on FDA's website but not presented at the September 15, 2020, Pediatric Advisory Committee meeting. The document was published with the incorrect product name for one of the post-marketing pediatric-focused safety reviews listed under Center for Biologics Evaluation and Research. This document corrects that error.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →